Crewe Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20
Closed -$4.66K 806
2025
Q1
$4.66K Buy
+20
New +$4.85K ﹤0.01% 489
2024
Q4
Sell
-44
Closed -$9.83K 740
2024
Q3
$9.83K Hold
44
﹤0.01% 496
2024
Q2
$8.96K Hold
44
﹤0.01% 714
2024
Q1
$9.61K Buy
+44
New +$9.69K ﹤0.01% 623
2023
Q1
Sell
-3
Closed -$706 947
2022
Q4
$706 Sell
3
-10
-77% -$1.95K ﹤0.01% 951
2022
Q3
$2K Buy
+13
New +$2.66K ﹤0.01% 1053
2021
Q3
Sell
-35
Closed -$8K 434
2021
Q2
$8K Sell
35
-29
-45% -$6.61K ﹤0.01% 297
2021
Q1
$14K Hold
64
﹤0.01% 243
2020
Q4
$11K Hold
64
﹤0.01% 250
2020
Q3
$10K Buy
+64
New +$10.1K ﹤0.01% 248

Other funds holding LH

Crewe Advisors's LH Position: Q2 2025 in Review

Crewe Advisors sold out of Labcorp (LH) in Q2 2025, closing a stake of 20 shares — an estimated $4.66K sold.

Crewe Advisors first reported a position in LH in Q3 2020 and held it in 10 quarters. The position peaked at $14K in Q1 2021. 974 funds tracked by Wall St. Rank hold LH as of Q2 2025.

  • Crewe Advisors reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
  • Crewe Advisors sold 20 Labcorp shares in Q2 2025, an estimated $4.66K.
  • Crewe Advisors first reported a position in Labcorp in Q3 2020 and held it in 10 quarters.
  • Crewe Advisors's Labcorp position peaked at $14K in Q1 2021.
  • 974 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Crewe Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.